Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new online seminar series is exploring the ‘ethics of exercise’ during coronavirus lockdown measures in the UK.

Image of person walking on autumnal leaves.

Run by David Lyreskog, a postdoctoral researcher in the Neuroscience, Ethics & Society (NEUROSEC) group in the Department of Psychiatry, the series looks at questions of why, how and when we should be exercising – both in lockdown and beyond. 

Current lockdown measures in the UK include limitations and restrictions on outdoor and group exercise, while in parallel exercise is generally encouraged for physical and mental health.

Topics covered in the multidisciplinary seminars include risk mitigation, social signalling, stigmatisation, and mental and physical health impacts.

 

The guidelines about exercise during the UK lockdown stood out to me as a topic of great importance to the public. As one of the few valid "excuses" permitting people to leave the home, there was – and still is – a remarkable amount that is unclear about what exactly we are supposed to be doing as a form of exercise, and when and how we should be doing it David Lyreskog, Department of Psychiatry, University of Oxford.

 

By running the series, David aims to ‘bridge the gap’ between the growing public interest in this topic – particularly during the pandemic – and the lack of attention it is receiving. 

There is a wide range of ethical issues specifically tied to exercise in these times, which need to be scrutinised.

  • To what extent do the guidelines trigger and/or worsen cases of eating disorders, depression and anxiety?
  • What do we signal to others by being out exercising in public, and is that something we should consider at all?
  • How, if at all, can we assess whether the exercise restrictions were implemented in an ethically justifiable manner?

 

David continues, ‘Ultimately, it boils down to fundamental, ethical questions about what people – as individuals and as groups – ought to be doing when there is no clear “right” answer to be had. My hope is that by analysing the ethical dimensions of our situation, we can learn from these experiences and improve our understanding of the relationships between exercise, health and morality – not only for any lockdown scenarios to come, but more generally for our future.’

The first seminar took place on 7 May and featured guest speaker Dr Jonathan Pugh from the Oxford Uehiro Centre for Practical Ethics, as well as discussion among attendees. It is available to watch here.

David will be running future sessions on Zoom at the following dates and times:

Session 2: 21 May 2020, 3-3.45pm

Session 3: 28 May 2020, 3-3.45pm

Session 4: 4 June 2020, 3-3.45pm

Please email David for details if you would like to attend.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

New Study will Investigate Brain Fog Symptoms in Post-Hospitalised COVID-19 Patients

C-Fog is a collaborative new study led by Oxford University researcher, Dr Maxime Taquet, which will investigate the reasons why brain fog or cognition problems affect patients after COVID-19 infection. With a better understanding of the mechanisms involved it may be possible to understand how to treat brain fog and help many thousands of people worldwide.

A New Experimental Study Investigated the Effects of Atorvastatin on Emotional Processing

Atorvastatin is one of a group of statins widely used to treat heart and blood vessel diseases. The medication works by lowering cholesterol in the blood. This new study shows that atorvastatin influences the way people experience certain emotions, giving us important insights about disorders such as anxiety and depression.

People with Long-COVID After Hospitalisation Face Limited Recovery After One Year

People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge, according to the latest results of a major national study looking at the long-term health impacts of COVID-19 on hospitalised patients.

The Effects of Social Media on Public Attention and Attitudes Towards COVID-19 Vaccines in the UK

A new study finds that media coverage of positive vaccine research can have a positive effect on overall social media sentiment, countering vaccine misinformation, but the effects wane over time.

Should Children be Offered Vaccination against COVID-19?

New Rapid Ethics Review from the UK Pandemic Ethics Accelerator investigates the question of whether or not children should be offered vaccination against COVID-19, a question which has raised significant ethical challenges.

New Clinical Trial to Test Drug for Diabetes in Reducing Risk of Alzheimer’s Dementia

A new study led through a collaboration between the Diabetes Trials Unit and the Department of Psychiatry at the University of Oxford, and the global healthcare company, Novo Nordisk, will examine whether semaglutide, a tablet used to treat diabetes, can change the course of the earliest changes that happen in the brains of people at risk of developing Alzheimer’s dementia.